Skip to content

Clinical trials

Phase 2 Heart Failure trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: United States Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20036
200411
20054
20065
20077
20084
20099
201016
20115
20127
201311
20149
20155
20168
201714
20186
20195
20206
20216
20226
202310
202412
20259
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119
Terminated39
Recruiting15
Withdrawn8
Active, not recruiting5
Unknown status4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer9
AstraZeneca7
Bristol-Myers Squibb5
Duke University5
Novartis Pharmaceuticals5
University of Pennsylvania5
Virginia Commonwealth University5
Cardurion Pharmaceuticals, Inc.4
Cytokinetics4
National Heart, Lung, and Blood Institute (NHLBI)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure194
Cardiovascular Diseases13
Cardiomyopathies9
Heart Failure, Diastolic9
Diabetes Mellitus8
Inflammation8
Heart Diseases7
Renal Insufficiency6
Heart Failure, Systolic5
Myocardial Infarction5

Trials

Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.